Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001250853-13-000147)

Filing Details

Accession Number:: 0001250853-13-000147
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-12-13 12:21:14
Reporting Period:: 2013-12-11

Filing Date:: 2013-12-13
Accepted Time:: 2013-12-13 12:21:14
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1561743	Kindred Biosciences Inc.	KIN	Pharmaceutical Preparations (2834)	461160142

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1593867	Raymond Townsend	C/O Kindred Biosciences, Inc. Burlingame CA 94010		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-12-12	3,000	$7.00	3,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Acquisiton	2013-12-11	20,000	$0.00	20,000	$7.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
20,000		2023-12-11	No	4	A	Direct

Footnotes

These shares were purchased through a directed share program in connection with the Issuer's initial public offering.
Granted pursuant to the Issuer's 2012 Equity Incentive Plan.
5,000 of the shares subject to the option will vest on December 11, 2014, with the remaining shares vesting in equal monthly installments over the ensuing 36 months, subject to the Reporting Person's continuous service as a director.